However, this biomarker criterion has been controversial because it has been shown that some patients with HF with a mildly reduced or preserved ejection fraction may have an NT-proBNP level below this value, especially in obese patients or at a very acute setting of decompensation when diuretic therapy has already been administered [22,23]. This evidence concerns the gene NPPB and hydrops fetalis.